ΦC31 integrase interacts with TTRAP and inhibits NFκB activation
- First Online:
- 117 Downloads
Phage ΦC31 integrase-mediated gene delivery is believed to be safer than using retroviral vectors since the protein confines its insertion of the target gene to a limited number of sites in mammalian genomes. To evaluate its safety in human cells, it is important to understand the interactions between this integrase and cellular proteins. Here we show that ΦC31 integrase interacts with TTRAP as presented by yeast two-hybrid and co-immunoprecipitation assays. Reducing the expression of endogenous TTRAP can increase the efficiency of ΦC31 integrase-mediated integration. A possible effect of interaction between ΦC31 integrase and TTRAP was highlighted by the fact that ΦC31 integrase inhibited the NFκB activation mediated by IL-1 in a dose-dependent manner. Because low dose of ΦC31 integrase can mediate considerable recombination events, we suggest that low dose of ΦC31 integrase be used when this integrase is applied in human cells.
KeywordsΦC31 integrase TTRAP NFκB
- 1.Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E, Radford I, Villeval JL, Fraser CC, Cavazzana-Calvo M, Fischer A (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348:255–256CrossRefPubMedGoogle Scholar
- 16.Quenneville SP, Chapdelaine P, Rousseau J, Beaulieu J, Caron NJ, Skuk D, Mills P, Olivares EC, Calos MP, Tremblay JP (2004) Nucleofection of muscle-derived stem cells and myoblasts with phi C31 integrase: stable expression of a full-length-dystrophin fusion gene by human myoblasts. Mol Ther 10:679–687CrossRefPubMedGoogle Scholar
- 22.Pype S, Declercq W, Ibrahimi A, Michiels C, Van Rietschoten JGI, Dewulf N, de Boer M, Vandenabeele P, Huylebroeck D, Remacle JE (2000) TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs) and that inhibits nuclear factor-kappa B activation. J Biol Chem 275:18586–18593CrossRefPubMedGoogle Scholar